Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0803-2025Class II

Access Intact PTH assay, a paramagnetic particle, chemiluminescent immunoassay for the quantitative...

Siemens Healthcare Diagnostics Inc. / initiated 2024-11-26 / Open, Classified / root cause: manufacturing process

Beckman Coulter, Inc. began a recall of Access Intact PTH assay, a paramagnetic particle, chemiluminescent immunoassay for the quantitative determination of intact parathyroid hormone (parathyrin... on . FDA classified it as Class II and gives the reason as "Beckman Coulter has identified that some Access PTH reagent packs from lot 339071 may be over- or under-filled in well 0. The dispensed material in well 0 could be above or below specification, risking sealing issues...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0803-2025
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Siemens Healthcare Diagnostics Inc.
Product
Access Intact PTH assay, a paramagnetic particle, chemiluminescent immunoassay for the quantitative determination of intact parathyroid hormone (parathyrin, PTH) levels in human serum and plasma using the Access Immunoassay Systems, Catalog Number A16972
Product code
CEW Radioimmunoassay, Parathyroid Hormone
Reason for recall
Beckman Coulter has identified that some Access PTH reagent packs from lot 339071 may be over- or under-filled in well 0. The dispensed material in well 0 could be above or below specification, risking sealing issues, contamination, instrument errors, delays, or inaccurate results with a negative bias and increase in imprecision. The issue was confirmed on 10 April 2024 by Beckman Coulter through an internal non-conformance (NC-INT-66585). The well 0 scale on the filling line began malfunctioning on the fill immediately before PTH. The malfunction was not noticed until the majority of PTH was filled.
Root cause tag
manufacturing process
FDA root cause
Nonconforming Material/Component
Action
An URGENT MEDICAL DEVICE RECALL notification letter dated 11/26/24 was sent to customers. ACTION: Discontinue using Access Intact PTH reagent lot 339071 and discard all remaining reagent packs from this lot. Beckman Coulter recommends sharing the content of this letter with your laboratory and/or medical director regarding the need to perform a retrospective review of the patient results generated from the affected Access Intact PTH reagent pack lot to determine if retesting is necessary. Beckman Coulter is investigating the root cause of this issue to prevent similar occurrences. Please share this information with your laboratory staff and retain this notification as part of your laboratory Quality System documentation. If you have forwarded any of the affected product listed above to another laboratory, please provide them a copy of this letter. So that we are assured you have received this important communication, please respond within 10 days in one of the following ways: Electronically, if you received this communication via email. Manually, complete and return the enclosed Response Form. If you have any questions regarding this notice, please contact our Customer Support Center; From our website: http://www.beckmancoulter.com
Quantity in commerce
362 units
Distribution
Worldwide distribution - US Nationwide and the country of Canada.
Product codes and lots
UDI: (01)15099590201937(17)241130(11)231201; Lot 339071

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0803-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0803-2025Class IIOngoingVoluntary: Firm initiated